Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05382325
Title A Study of MK-1484 as Monotherapy and in Combination With Pembrolizumab (MK-3475) In Advanced or Metastatic Solid Tumors (MK-1484-001)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Merck Sharp & Dohme LLC
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | NLD | CAN

Facility Status City State Zip Country Details
Sanford Cancer Center ( Site 0005) RECRUITING Sioux Falls South Dakota 57104 United States Details
NEXT Oncology ( Site 0001) RECRUITING San Antonio Texas 78229 United States Details
Princess Margaret Cancer Centre-Division of Medical Oncology and Hematology ( Site 0011) RECRUITING Toronto Ontario M5G 2M9 Canada Details
Rambam Health Care Campus-Oncology ( Site 0021) RECRUITING Haifa 3109601 Israel Details
Sheba Medical Center-ONCOLOGY ( Site 0020) RECRUITING Ramat Gan 5265601 Israel Details
Nederlands Kanker Instituut - Antoni van Leeuwenhoek (NKI-AVL) ( Site 0035) RECRUITING Amsterdam Noord-Holland 1066CX Netherlands Details
Erasmus Medisch Centrum-Medical Oncology ( Site 0036) RECRUITING Rotterdam Zuid-Holland 3015 GD Netherlands Details
Universitair Medisch Centrum Utrecht-Medical Oncology ( Site 0037) RECRUITING Utrecht 3584 CX Netherlands Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field